By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits under an agreement announced today by the firms.

The partners did not disclose terms of the agreement, but said it is a multi-year distribution and supply pact. They also did not specify which Affy kits would contain the oligos.

San Diego-based TriLink makes custom oligos, modified nucleoside triphosphates and CleanAmp PCR products for the diagnostics and OEM markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.